0001047469-19-005694 Sample Contracts

CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT

Convertible Promissory Note Purchase Agreement • October 11th, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Convertible Promissory Note Purchase Agreement
• Filed
  October 11th, 2019
• Company
  Gemphire Therapeutics Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Convertible Promissory Note Purchase Agreement (this “Agreement”) is made and entered into as of by and between NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (the “Purchaser”).

CONVERTIBLE PROMISSORY NOTE CONVERSION AGREEMENT

Convertible Promissory Note Conversion Agreement • October 11th, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Convertible Promissory Note Conversion Agreement
• Filed
  October 11th, 2019
• Company
  Gemphire Therapeutics Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Convertible Promissory Note Conversion Agreement (this “Agreement”) is made and entered into as of , 2019 by and between NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and , a corporation (the “Noteholder”), with reference to the following:

WEWORK MEMBERSHIP AGREEMENT Membership Details Form

Gemphire Therapeutics Inc. • October 11th, 2019 • Pharmaceutical preparations • New York

• Company
  Gemphire Therapeutics Inc.
• Filed
  October 11th, 2019
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Service Retainer: $98,325 You shall not be permitted to move into the Office Space until the Service Retainer has been fully paid, as described in Sections 4(a) and 5(a) of this Agreement.

Contract

Gemphire Therapeutics Inc. • October 11th, 2019 • Pharmaceutical preparations • Delaware

• Company
  Gemphire Therapeutics Inc.
• Filed
  October 11th, 2019
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE IS SUBJECT TO, AND IN CERTAIN CASES PROHIBITED BY, THE TERMS AND CONDITIONS OF A CERTAIN STOCKHOLDERS’ AGREEMENT BY AND AMONG NEUROBO PHARMACEUTICALS, INC., A DELAWARE CORPORATION (THE “COMPANY”), AND CERTAIN HOLDERS OF STOCK OF THE COMPANY. BY ACCEPTING ANY INTEREST IN THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE, THE PERSON ACCEPTING SUCH INTEREST, TO THE EXTENT NOT THERETOFORE A PARTY TO SUCH STOCKHOLDERS’ AGREEMENT, SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY THE PROVISIONS OF THAT STOCKHOLDERS’ AGREEMENT, IF STILL THEN IN EFFECT, INCLUDING CERTAIN RESTRICTIONS ON TRANSFER, OWNERSHIP AND VOTING SET FORTH THEREIN. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.